Drug Helps Fight Early-Stage Breast Cancer

Published on June 4, 2021

A twice-daily pill can dramatically reduce the risk of breast cancer recurrence in women who are genetically prone to the disease, researchers report. The pill – olaparib (Lynparza) – works by blocking a natural enzyme called PARP that normally fixes DNA damage in healthy…

Read Full Article (External Site)